Russell Investments Group
EXAS

Russell Investments Group’s Exact Sciences EXAS Stock Holding History

Russell Investments Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-37,628
Closed -$3.82M – 4262
2025
Q4 		$3.82M Sell
37,628
-17,183
-31% -$1.38M ﹤0.01% 1484
2025
Q3 		$3M Sell
54,811
-16,704
-23% -$835K ﹤0.01% 1629
2025
Q2 		$3.8M Sell
71,515
-166,696
-70% -$8.47M ﹤0.01% 1375
2025
Q1 		$10.3M Buy
238,211
+11,336
+5% +$574K 0.01% 812
2024
Q4 		$12.7M Sell
226,875
-5,823
-3% -$362K 0.02% 718
2024
Q3 		$15.9M Sell
232,698
-8,842
-4% -$499K 0.02% 661
2024
Q2 		$10.2M Buy
241,540
+20,299
+9% +$1.12M 0.02% 798
2024
Q1 		$15.3M Buy
221,241
+24,625
+13% +$1.56M 0.02% 652
2023
Q4 		$14.6M Buy
196,616
+41,978
+27% +$2.75M 0.03% 619
2023
Q3 		$10.6M Buy
154,638
+122,248
+377% +$10.4M 0.02% 733
2023
Q2 		$3.05M Sell
32,390
-4,820
-13% -$376K 0.01% 1317
2023
Q1 		$2.5M Buy
37,210
+5,262
+16% +$338K ﹤0.01% 1445
2022
Q4 		$1.59M Sell
31,948
-358
-1% -$14.6K ﹤0.01% 1732
2022
Q3 		$1.06M Sell
32,306
-5,407
-14% -$223K ﹤0.01% 1903
2022
Q2 		$1.5M Sell
37,713
-548,616
-94% -$29.3M ﹤0.01% 1739
2022
Q1 		$41M Buy
586,329
+148,057
+34% +$10.8M 0.07% 335
2021
Q4 		$34.1M Buy
438,272
+178,478
+69% +$15.8M 0.05% 413
2021
Q3 		$24.7M Buy
259,794
+56,208
+28% +$5.93M 0.04% 514
2021
Q2 		$25.4M Sell
203,586
-7,704
-4% -$919K 0.04% 501
2021
Q1 		$27.7M Sell
211,290
-141,356
-40% -$19.3M 0.05% 455
2020
Q4 		$46.9M Sell
352,646
-2,425
-0.7% -$293K 0.09% 250
2020
Q3 		$36.2M Sell
355,071
-26,428
-7% -$2.28M 0.08% 290
2020
Q2 		$33.2M Sell
381,499
-32,790
-8% -$2.62M 0.07% 291
2020
Q1 		$24M Buy
414,289
+234,835
+131% +$19.1M 0.06% 335
2019
Q4 		$16.6M Sell
179,454
-109,570
-38% -$9.63M 0.03% 625
2019
Q3 		$26.3M Sell
289,024
-71,028
-20% -$8.09M 0.05% 425
2019
Q2 		$42.1M Sell
360,052
-38,259
-10% -$3.85M 0.08% 307
2019
Q1 		$34.2M Sell
398,311
-51,508
-11% -$4.38M 0.06% 371
2018
Q4 		$28.1M Sell
449,819
-162,093
-26% -$11.1M 0.06% 352
2018
Q3 		$47.9M Buy
611,912
+54,863
+10% +$3.58M 0.09% 233
2018
Q2 		$33.4M Sell
557,049
-69,576
-11% -$3.74M 0.07% 317
2018
Q1 		$25.1M Buy
626,625
+125,208
+25% +$6.11M 0.04% 503
2017
Q4 		$27.4M Buy
501,417
+174,948
+54% +$9.34M 0.05% 490
2017
Q3 		$15.4M Buy
326,469
+151,443
+87% +$6.1M 0.03% 743
2017
Q2 		$6.19M Buy
175,026
+55,544
+46% +$1.71M 0.01% 1127
2017
Q1 		$2.82M Buy
119,482
+63,519
+114% +$1.26M 0.01% 1560
2016
Q4 		$758K Buy
+55,963
New +$903K ﹤0.01% 2311

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Russell Investments Group's EXAS Position: Q1 2026 in Review

Russell Investments Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 37,628 shares — an estimated $3.82M sold.

Russell Investments Group first reported a position in EXAS in Q4 2016 and held it in 37 quarters. The position peaked at $47.9M in Q3 2018. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Russell Investments Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Russell Investments Group sold 37,628 Exact Sciences shares in Q1 2026, an estimated $3.82M.
  • Russell Investments Group first reported a position in Exact Sciences in Q4 2016 and held it in 37 quarters.
  • Russell Investments Group's Exact Sciences position peaked at $47.9M in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.